标题
Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 158, Issue -, Pages 114170
出版商
Elsevier BV
发表日期
2022-12-31
DOI
10.1016/j.biopha.2022.114170
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall
- (2022) Sabina Ugovšek et al. Journal of Clinical Medicine
- Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
- (2021) R. Scott Wright et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 and cancer: Rethinking the link
- (2021) Khadijeh Mahboobnia et al. BIOMEDICINE & PHARMACOTHERAPY
- PCSK9 vaccine: so near, yet so far!
- (2021) Amirhossein Sahebkar et al. EUROPEAN HEART JOURNAL
- Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats
- (2021) Amir Abbas Momtazi-Borojeni et al. Journal of Diabetes Research
- PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
- (2021) Maciej Banach et al. Archives of Medical Science
- PCSK9 Inhibition-Based Therapeutic Approaches: An Immunotherapy Perspective
- (2021) Amir Abbas Momtazi-Borojeni et al. CURRENT MEDICINAL CHEMISTRY
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Inhibition of PCSK9 and Liver Function
- (2020) Antoine Rimbert et al. JAMA Cardiology
- Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system
- (2019) Amir Abbas Momtazi-Borojeni et al. ATHEROSCLEROSIS
- Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
- (2019) Paul Guedeney et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
- (2019) David M. Charytan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 hapten multicopy displayed onto Carrier Protein nanoparticle: an anti-atherosclerosis vaccine
- (2019) Shasha You et al. ACS Biomaterials-Science & Engineering
- PCSK9 and inflammation: a review of experimental and clinical evidence
- (2019) Amir Abbas Momtazi-Borojeni et al. European Heart Journal-Cardiovascular Pharmacotherapy
- 4120Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer
- (2019) A A Momtazi-Borojeni et al. EUROPEAN HEART JOURNAL
- P704Nanoliposomal anti-PCSK9 vaccine ameliorates glucose intolerance and insulin resistance in diabetic rats
- (2019) A A Momtazi-Borojeni et al. EUROPEAN HEART JOURNAL
- P6194Therapeutic effect of nanoliposomal anti-PCSK9 vaccine on hypercholesterolemia and atherosclerosis in C57BL/6 mice
- (2019) A A Momtazi-Borojeni et al. EUROPEAN HEART JOURNAL
- Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units
- (2019) Tannaz Jamialahmadi et al. Journal of Clinical Medicine
- Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
- (2019) Amir Abbas Momtazi-Borojeni et al. BMC Medicine
- Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β‐Oxidation
- (2019) Danyu Wu et al. Journal of the American Heart Association
- Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting
- (2018) BinBin Zheng-Lin et al. DRUGS
- Inhibiting PCSK9 — biology beyond LDL control
- (2018) Robert M. Stoekenbroek et al. Nature Reviews Endocrinology
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of PCSK9 by nutraceuticals
- (2017) Amir Abbas Momtazi et al. PHARMACOLOGICAL RESEARCH
- A Therapeutic Peptide Vaccine Against PCSK9
- (2017) Yajie Pan et al. Scientific Reports
- Daily Fasting Blood Glucose Rhythm in Male Mice: A Role of the Circadian Clock in the Liver
- (2016) Hitoshi Ando et al. ENDOCRINOLOGY
- PCSK9 inhibitors in sepsis: a new potential indication?
- (2016) Amir Abbas Momtazi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
- (2014) Gergana Galabova et al. PLoS One
- Recent advances in pharmacotherapy for hypertriglyceridemia
- (2014) Amirhossein Sahebkar et al. PROGRESS IN LIPID RESEARCH
- The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway
- (2013) A.L. Catapano et al. ATHEROSCLEROSIS
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
- (2013) Amirhossein Sahebkar et al. CARDIOVASCULAR DRUGS AND THERAPY
- Genetics: A gene of rare effect
- (2013) Stephen S. Hall NATURE
- PCSK9 Inhibitors: Potential in Cardiovascular Therapeutics
- (2013) Rose Q. Do et al. Current Cardiology Reports
- Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice
- (2012) Elena Fattori et al. JOURNAL OF LIPID RESEARCH
- Determination of Prooxidant—Antioxidant Balance After Acute Coronary Syndrome Using a Rapid Assay: A Pilot Study
- (2009) Majid Ghayour-Mobarhan et al. ANGIOLOGY
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started